Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus Infection Prevention”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Large-scale testing (Phase 3)Looking for participantsNCT07232706
What this trial is testing

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Who this might be right for
RSV Immunization
Centre Hospitalier Annecy Genevois 1,000
Large-scale testing (Phase 3)Study completedNCT05071313
What this trial is testing

An Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Who this might be right for
Influenza, Human PreventionRespiratory Syncytial Viruses Prevention
Janssen Vaccines & Prevention B.V. 777
Large-scale testing (Phase 3)Study completedNCT03979313
What this trial is testing

Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)

Who this might be right for
Respiratory Syncytial Virus Infections
AstraZeneca 3,012
Large-scale testing (Phase 3)Study completedNCT03959488
What this trial is testing

Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children

Who this might be right for
Respiratory Syncytial Virus Infections
AstraZeneca 925
Large-scale testing (Phase 3)Study completedNCT05083585
What this trial is testing

A Study Evaluating the Immunogenicity of Different Clinical Trial Materials of Ad26.RSV.preF- Based Vaccine in Adults Aged 60 - 75 Years Old

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Vaccines & Prevention B.V. 250
Early research (Phase 1)Study completedNCT03473002
What this trial is testing

A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults

Who this might be right for
Antiviral ProphylaxisRespiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 21
Large-scale testing (Phase 3)Study completedNCT05070546
What this trial is testing

An Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Who this might be right for
Respiratory Syncytial Virus Infection Prevention
Janssen Vaccines & Prevention B.V. 1,124
Not applicableActive Not RecruitingNCT07756528
What this trial is testing

Stakeholder-Informed RSV Prevention Economic Model in Botswana

Who this might be right for
RSV
University of California, San Diego 40
Large-scale testing (Phase 3)Study completedNCT01006629
What this trial is testing

Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children

Who this might be right for
Respiratory Syncytial Virus InfectionPremature BirthBronchopulmonary Dysplasia+1 more
Abbott 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT07208461
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection Prevention
Guangzhou Patronus Biotech Co., Ltd. 700
Not applicableStudy completedNCT00384462
What this trial is testing

Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 346
Not applicableStudy completedNCT02016690
What this trial is testing

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie 312
Not applicableLooking for participantsNCT06881953
What this trial is testing

Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France

Who this might be right for
RSV Infection
Assistance Publique - Hôpitaux de Paris 400
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120
Testing effectiveness (Phase 2)Ended earlyNCT03982199
What this trial is testing

An Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

Who this might be right for
Respiratory Syncytial VirusesRespiratory Tract Diseases
Janssen Vaccines & Prevention B.V. 5,815
Not applicableStudy completedNCT07164430
What this trial is testing

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Nicola Irwin 2,792
Early research (Phase 1)Study completedNCT00192504
What this trial is testing

Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection

Who this might be right for
Respiratory Syncytial Virus Prophylaxis
MedImmune LLC 31
Large-scale testing (Phase 3)Study completedNCT05101486
What this trial is testing

An Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Vaccines & Prevention B.V. 755
Large-scale testing (Phase 3)Study completedNCT05437510
What this trial is testing

Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life

Who this might be right for
RSV ImmunizationHealthy Volunteer
Sanofi Pasteur, a Sanofi Company 8,057
Large-scale testing (Phase 3)Study completedNCT02325791
What this trial is testing

Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Regeneron Pharmaceuticals 1,177
Next Page